Phase III Clinical Trial of "Botulax®" to Treat Children With Cerebral Palsy
Status:
Completed
Trial end date:
2014-08-01
Target enrollment:
Participant gender:
Summary
To compare the safety and efficacy of Botulax Inj.®(Botulinum toxin type A, Hugel, South
Korea) with Botox Inj.® (Botulinum toxin type A, Allergan, USA) in the treatment of cerebral
palsy in children.
Phase:
Phase 3
Details
Lead Sponsor:
Hugel
Treatments:
abobotulinumtoxinA Botulinum Toxins Botulinum Toxins, Type A incobotulinumtoxinA onabotulinumtoxinA